DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Murthy RK, Loi S, Okines A, Paplomata E, Hamilton E, Hurvitz SA. et al.
Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer.
N Engl J Med 2019;
382: 597-609
Access:
We do not assume any responsibility for the contents of the web pages of other providers.